WallStreetZenWallStreetZen

NASDAQ: BOLT
Bolt Biotherapeutics Inc Earnings & Revenue

BOLT past revenue growth

How has BOLT's revenue growth performed historically?
Company
37.48%
Industry
165.61%
Market
17.84%
BOLT's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
BOLT's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
BOLT's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

BOLT earnings and revenue history

Current Revenue
$7.9M
Current Earnings
-$69.2M
Current Profit Margin
-878.6%

BOLT Return on Equity

Current Company
-51.2%
Current Industry
-63.6%
Current Market
188%
BOLT's Return on Equity (-51.2%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when BOLT announces earnings.

BOLT Return on Assets

Current Company
-37.8%
Current Industry
3%
BOLT is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

BOLT Return on Capital Employed

Current Company
-49.66%
Current Industry
19.6%
BOLT has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BOLT vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
BOLT$7.88M-$64.39M-$69.20M+146.02%N/A
EFTR$0.00-$32.78M-$35.81M-100.00%N/A
CLNN$654.00k-$42.81M-$49.50M+129.56%N/A
MLECN/AN/AN/AN/AN/A
QTTB$1.16M-$110.32M-$112.96M-26.32%N/A

BOLT earnings dates

Next earnings date
May 9, 2024

Bolt Biotherapeutics Earnings & Revenue FAQ

What were BOLT's earnings last quarter?

On Invalid Date, Bolt Biotherapeutics (NASDAQ: BOLT) reported Q4 2023 earnings per share (EPS) of -$0.47, up 11.32% year over year. Total Bolt Biotherapeutics earnings for the quarter were -$17.90 million. In the same quarter last year, Bolt Biotherapeutics's earnings per share (EPS) was -$0.53.

If you're new to stock investing, here's how to buy Bolt Biotherapeutics stock.

What was BOLT's earnings growth in the past year?

As of Q1 2024, Bolt Biotherapeutics's earnings has grown year over year. Bolt Biotherapeutics's earnings in the past year totalled -$69.20 million.

What is BOLT's earnings date?

Bolt Biotherapeutics's earnings date is Invalid Date. Add BOLT to your watchlist to be reminded of BOLT's next earnings announcement.

What was BOLT's revenue last quarter?

On Invalid Date, Bolt Biotherapeutics (NASDAQ: BOLT) reported Q4 2023 revenue of $2.09 million up 48.05% year over year. In the same quarter last year, Bolt Biotherapeutics's revenue was $1.41 million.

What was BOLT's revenue growth in the past year?

As of Q1 2024, Bolt Biotherapeutics's revenue has grown 37.48% year over year. This is 128.14 percentage points lower than the US Biotechnology industry revenue growth rate of 165.61%. Bolt Biotherapeutics's revenue in the past year totalled $7.88 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.